Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
1.1TWD
28.57 MTWD
592.50 MTWD
About GENETICS GENERATION ADVANCEMENT COR
Sector
Industry
CEO
Cheng Hsien Tsai
Website
Headquarters
Taipei
Founded
2008
ISIN
TW0004160007
FIGI
BBG001W71XR3
Genetics Generation Advancement Corp. engages in the provision of genetic testing, molecular diagnostics, biotechnology services, personal health-related testing services, biological information services, and health care services. It offers testing, pre-implantation stage, prenatal stage, newborn medical examination, adult healthcare health management genetic testing, adult healthcare cancer pharmacogenetics testing and other related testing services. The company was founded on November 21, 2008 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4160 is 49.8 TWD — it has decreased by 6.04% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange GENETICS GENERATION ADVANCEMENT COR stocks are traded under the ticker 4160.
GENETICS GENERATION ADVANCEMENT COR is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
4160 stock is 6.43% volatile and has beta coefficient of −0.49. Check out the list of the most volatile stocks — is GENETICS GENERATION ADVANCEMENT COR there?
Yes, you can track GENETICS GENERATION ADVANCEMENT COR financials in yearly and quarterly reports right on TradingView.
4160 stock has fallen by 1.39% compared to the previous week, the month change is a 16.76% rise, over the last year GENETICS GENERATION ADVANCEMENT COR has showed a 53.92% increase.
4160 net income for the last quarter is 6.88 M TWD, while the quarter before that showed 4.88 M TWD of net income which accounts for 40.89% change. Track more GENETICS GENERATION ADVANCEMENT COR financial stats to get the full picture.
Today GENETICS GENERATION ADVANCEMENT COR has the market capitalization of 1.35 B, it has increased by 11.26% over the last week.
Yes, 4160 dividends are paid annually. The last dividend per share was 0.48 TWD. As of today, Dividend Yield (TTM)% is 0.82%. Tracking GENETICS GENERATION ADVANCEMENT COR dividends might help you take more informed decisions.
GENETICS GENERATION ADVANCEMENT COR dividend yield was 1.30% in 2023, and payout ratio reached 45.00%. The year before the numbers were 1.66% and 42.95% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4160 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENETICS GENERATION ADVANCEMENT COR stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENETICS GENERATION ADVANCEMENT COR technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENETICS GENERATION ADVANCEMENT COR stock shows the strong buy signal. See more of GENETICS GENERATION ADVANCEMENT COR technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENETICS GENERATION ADVANCEMENT COR EBITDA is 34.02 M TWD, and current EBITDA margin is 5.74%. See more stats in GENETICS GENERATION ADVANCEMENT COR financial statements.